Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...
Probably not, but Arne Slot hasn’t helped. Pep Guardiola has rarely enjoyed his trips to Anfield. In nine visits as Manchester City boss he’s only won once and that was without a crowd in ...
The Best of Car Talk America's funniest auto mechanics take calls from weary car owners all over the country, and crack wise while they diagnose Dodges and dismiss Diahatsus.
California biotech Calibr and partner AbbVie have reported the first clinical data on a new CAR-T technology, which uses "switchable" cells that aim to eliminate the life-threatening side-effects ...